Is Wireless Capsule pH Monitoring Better Than Catheter Systems?

이준성 대한소화기 기능성질환∙운동학회 2012 Journal of Neurogastroenterology and Motility (JNM Vol.18 No.2

중국의 상업적 도전과 미・중 해양패권 경쟁 구조의 전환: 서태평양 항만 네트워크를 중심으로

이준성 한양대학교 아태지역연구센터 2025 중소연구 Vol.49 No.3

본 연구는 미국이 형성한 군사 중심의 해양질서 속에서, 항만 네트워크를 중심으로 중국의 상업적 도전이 본격화됨에 따라 미・중 해양패권 경쟁 구조가 복합적 양상으로 전환되고 있다고 주장한다. 이러한 구조적 전환은 특히 서태평양을 중심으로 급속히 전개되고 있지만, 기존 연구에서는 이 부분을 충분히 조명하지 못하였다. 이러한 연구 공백을 메우고자 본 연구는 다음과 같은 두 가지 분석적 접근을 시도하였다. 첫째, 중국의 상업적 도전에 따른 미・중 해양패권 경쟁의 구조적 전환을 경쟁(competitor), 위협(threat), 적성(enemy) 등 세 단계로 구분하여 검토하였다. 21세기 중국은 근해에서 군사력을 증강함에 따라 미국과 남중국해 문제를 놓고 군사적 갈등을 지속해왔다. 반면, 일대일로 출범 이후에는 항만 네트워크 구축을 통해 점진적으로 국제적 영향력 확대하여 상업 주도 해양질서를 형성하고자 노력해왔다. 이에 대응하여 미국은 군사적 역량 강화를 이어가는 동시에, 트럼프 2기 행정부 집권 이후 중국의 해상 무역과 글로벌 공급망 네트워크를 약화시키기 위한 전략을 본격화하기 시작하였다. 이에 따라 미・중 해양패권 경쟁은 군사와 상업 분야에서 복합적인 양상으로 심화되고 있다. 둘째, 중국의 상업적 도전이 미・중 해양패권 경쟁에 미칠 영향을 동해 및 남중국해를 중심으로 한 서태평양 항만 네트워크 사례를 통해 분석하였다. 서태평양 항만 네트워크는 중국이 대미 견제를 위한 세력 형성과 국제협력의 기반으로 활용되고 있다. 동해 네트워크는 중국 북방 내륙의 해양 진출을 위한 육상 출구이자, 최근 증가하는 군사 활동을 고려할 때 북・중・러 삼각 해양협력의 최전선으로 부상할 잠재력을 지닌다. 남중국해 네트워크는 중국의 해양 활동 반경을 확대하기 위한 주요 기반시설로서, 아세안 국가와의 광범위한 정치・경제적 협력을 견인하여 중국 주도의 새로운 해양안보 지형을 형성하기 위한 거점으로 기능하고 있다. 이러한 분석을 통해 본 연구는 미・중 해양패권 경쟁의 구조적 전환은 국지적 군사충돌을 넘어 상업・외교・제도적 차원을 포괄하는 복합적 해양질서 경쟁으로 심화되고 있음을 확인하였다. 이에 따라 본 연구는 다음의 두 가지 시사점을 제시한다. 첫째, 중국의 상업적 도전에 따른 미・중 해양패권 경쟁의 구조적 전환이 새로운 해양질서의 형성으로 이어질 수 있다는 점이다. 둘째, 군사 기지를 중심으로 세력권을 확장한 미국과 달리 중국은 항만을 통해 우회적으로 접근하고 있으므로, 향후 활동에 대한 체계적인 분석과 지속적인 추적이 요구된다는 점이다. This study examines the impact of China's commercial expansion on U.S.-China maritime rivalry by arguing that China's power projection through global port networks is transforming the competition into a complex, multi-domain rivalry. While this competition is rapidly intensifying, particularly in the Western Pacific, existing literature has not paid sufficient attention to this evolving dynamic. To address this gap, this study employs the following analytical approaches: First, the structural transition of the U.S.-China maritime rivalry, driven by China's commercial expansion through port networks, is examined across three phases of evolving competition. Characterized by changes in rivalry images, these phases are categorized as competitor, threat, and enemy, respectively Second, the impact of China’s commercial expansion is analyzed through a case study of its port networks across the Western Pacific. This analysis further explores China’s approach to establish and leverage these ports in host countries to project power, thereby identifying the potential influence and strategic role of these networks in the U.S.-China rivalry. This study concludes that this structural transition is deepening into a complex, multi-domain competition for maritime order, transcending regional military clashes to encompass commercial, diplomatic, and institutional dimensions. Against this backdrop, this study offers two key implications: First, the transformation of U.S.-China rivalry may lead to the formation of a new, commercially-led maritime order. Second, it necessitates further research and continuous tracking of China's global port networks to anticipate its future activities.

『高麗史』 刑法志 職制 편목의 분석과 고려전기의 ‘判’

이준성,이인재 한국중세사학회 2014 한국중세사연구 Vol.0 No.40

This paper examined the establishment of individual penal law, which is collected in the ‘Criminal law Section(刑法志)’ of Goryeosa(高麗史). In Goreyo(高麗), After the basic law was established in the ruling time of king seongjong(成宗), the new law was legislated by the ‘royal command(王命)’ to be adjusted to the social changes effectively. There are various kinds of royal commands such as ‘Pan(判)’, ‘Je(制)’ and ‘Gyo(敎)’. Among them, many Pans are collected in the book as royal commands. However, ‘Pan’ has specifics that are much similar to the articles of the law, and is not collected in the sega(世家) of Goryeosa(高麗史) and Goryeosajeolyo(高麗史節要). Considering these specifics, it is possible that Pans were quoted from different sources from other articles. Eventually, Some of the royal commands were compiled as ‘Pan’, and preserved in ‘Sikmokdogam(拭目都監)’. In the compiling process, the original proposal was often modified and reorganized in the context of the law, added or shortened when necessary.

Deep Vein Thrombosis in Patients with Pulmonary Embolism: Prevalance, Clinical Significance and Outcome

이준성,문통,김태훈,김세영,최준영,이경복,권유진,송석희,김수현,김해옥,황호경,김민지,이영경 대한혈관외과학회 2016 Vascular Specialist International Vol.32 No.4

Purpose: Deep venous thrombosis (DVT) and pulmonary embolism (PE) are considered as similar disease entities representing different clinical manifestations. The objectives of this study were: 1) to determine the prevalence and outcome of DVT in patients with PE; 2) to identify additional risk factors for PE-related unfavorable outcome and 30-day all-cause mortality; and 3) to establish the clinical importance of screening for concomitant DVT.Materials and Methods: From January 2013 to December 2015, a total of 141 patients with confirmed PE were evaluated. The prevalence and outcome of DVT in patients with PE was determined. Furthermore, the potential risk factors for PE-related unfavorable outcome and 30-day all-cause mortality were also analyzed. Results: The prevalence of concomitant DVT was 45.4%. PE-related unfavorable outcome was observed in 21.9% of all concomitant DVT, with all-cause mortality of 21.9%. There was no significant relationship between the presence of concomitant DVT and the development of PE-related unfavorable outcome or all-cause mortality. Our results indicated that heart rate >100/min and peripheral oxygen saturation <90% were independent predictors for PE-related unfavorable outcome. Regarding all-cause mortality, active malignancy and hypotension or shock were significant risk factors.Conclusion: Our findings demonstrate that approximately half of patients with PE possess DVT. However, this study failed to establish any clinical significance of concomitant DVT for PE-related unfavorable outcome and all-cause mortality. Tachycardia and hypoxemia were identified as significant predictors for PE-related unfavorable outcome along with active malignancy and hypotension or shock as significant risk factors of all-cause mortality.

집담회 특강 : 호산구

이준성 대한소아알레르기호흡기학회 1992 Allergy Asthma & Respiratory Disease Vol.2 No.1

N/A

우리 것을 지키며 : 신유, 그 놀라운 은총 ; 네 믿은 대로 될지어다

이준성 기독교대한성결교회 활천사 2013 활천 Vol.712 No.-

목회자를 돕는 활천입니다 : 초청설교 ; 복음이 능력입니다

이준성 기독교대한성결교회 활천사 2012 활천 Vol.702 No.-

齒牙 및 齒周疾患에 使用되는 藥物에 관한 文獻的 考察

이준성,유현신,서형식,노석선,Lee, Jun-Seong,Rheu, Hyun-Sin,Seo, Hyung-Sik,Rho, Seok-Seon 대한한방안이비인후피부과학회 2001 한방안이비인후피부과학회지 Vol.14 No.2

The result were as follows: 1. Apply the drug to the Dental and Paradental digease is used to be very busy on the Gypsum Fibrosum( 石膏) and Asari herba cum Radice(細辛). 2. Apply the drug to the Dental and Paradental digease is clearing away heat and helping sweat 3. Apply the drug to the Dental and Paradental digease is cold and hot. 4. Apply the drug to the Dental and Paradental digease is pungent, bitter and sweet. 5. Apply the drug to the Dental and Paradental digease is non-toxic. 6. Apply the drug to the Dental and Paradental digease is used to be very busy on the chanel of liver and stomach.

성결과 목회 -목회자 에세이 : 목적이 이끄는 삶

이준성 현대기독교역사연구소 2012 성결교회와 신학 Vol.28 No.-

Short-term Efficacy and Safety of Faricimab Switching in Neovascular Age-related Macular Degeneration Previously Treated with Anti-vascular Endothelial Growth Factor

이준성,김창룡,임선택,김영휘 한국망막학회 2025 Journal of Retina Vol.10 No.1

Purpose: To evaluate the short-term efficacy and safety of intravitreal faricimab injection (IFI) in patients with neovascular age-related macular degeneration (nAMD) previously treated with another anti-vascular endothelial growth factor (anti-VEGF). Methods: We retrospectively reviewed the medical records of patients with nAMD refractory to previous anti-VEGF treatment who were switched to faricimab from June 2023 to July 2024. A good responder was defined as a case with complete absence of subretinal fluid (SRF) or intraretinal fluid (IRF) 8 weeks after IFI, whereas a poor responder was defined as having residual SRF or IRF 8 weeks after IFI. We evaluated best-corrected visual acuity (BCVA), central subfield retinal thickness (CST), sub-foveal choroidal thickness (SFCT), maximum height of pigment epithelial detachment (PED) and the presence of SRF or IRF, and the presence of optical coherence tomography parameters of nAMD at baseline (before the injection of faricimab) and 8 weeks and 16 weeks after faricimab switching. All adverse events following faricimab injection were analyzed. Results: Seventy-two eyes of 69 patients were included. There was no significant BCVA change after IFI. CST, SFCT and maximum PED height were significantly decreased 8 weeks and 16 weeks after faricimab switching compared to baseline (all p < 0.05). A fluid-free state was reached in 39% at 16 weeks. The poor responder group had a higher number of brolucizumab injections before switching compared to the good responder group (1.1 ± 1.9 vs. 2.4 ± 3.3, p = 0.04). The good responder group had more cases without SRF before switching and lower baseline CST than the poor responder group (all p < 0.05). There were no severe adverse events after IFI. Conclusions: Faricimab was safe and anatomically effective, though it did not produce functional improvements. IFI could serve as another option in the treatment of patients with nAMD treated with previous anti-VEGF.